Use of spermidine synthase (spee) as a marker for breast cancer

Details Use of spermidine synthase (spee) as a marker for breast cancer Use of spermidine synthase (spee) as a marker for breast cancer

G - Physics

01

N

G01N 33/574 (2006.01)

Patent

CA 2536536

The present invention relates to the diagnosis of breast cancer. It discloses the use of spermidine synthase (SPEE) in the diagnosis of breast cancer. It relates to a method for diagnosis of breast cancer from a liquid sample, derived from an individual by measuring SPEE in said sample. Measurement of SPEE can, e.g., be used in the early detection or diagnosis of breast cancer.

L'invention se rapporte au diagnostic du cancer du sein. Elle concerne l'utilisation de la spermidine synthase (SPEE) dans le diagnostic du cancer du sein. Elle porte aussi sur un procédé de diagnostic du cancer du sein à partir d'un échantillon liquide, issu d'un individu, par la mesure de la spermidine synthase dans cet échantillon. La mesure de la spermidine synthase peut, par exemple, être utilisée dans la détection ou le diagnostic précoce du cancer du sein.

Affiliated with

Also associated with

Rating

Use of spermidine synthase (spee) as a marker for breast cancer does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of spermidine synthase (spee) as a marker for breast cancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of spermidine synthase (spee) as a marker for breast cancer will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2083539